{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:20:54Z","timestamp":1789953654178,"version":"4.0.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"CNRS","doi-asserted-by":"publisher","award":["UPR3212"],"award-info":[{"award-number":["UPR3212"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"University of Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejmech.2018.01.049","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T17:17:54Z","timestamp":1517419074000},"page":"163-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Phenylpyridine-2-ylguanidines and rigid mimetics as novel inhibitors of TNF\u03b1 overproduction: Beneficial action in models of neuropathic pain and of acute lung inflammation"],"prefix":"10.1016","volume":"147","author":[{"given":"Maud","family":"Bollenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Salvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Daubeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-8329","authenticated-orcid":false,"given":"Patrick","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muris","family":"Humo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Letellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a J.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Bihel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Bourguignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-4852","authenticated-orcid":false,"given":"Pascal","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Obrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Frossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Barrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-9502","authenticated-orcid":false,"given":"Martine","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.01.049_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pupt.2007.08.001","article-title":"Regulation of peroxisome proliferator-activated receptor-\u03b1 expression during lung inflammation","volume":"21","author":"Becker","year":"2008","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2018.01.049_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1465-9921-6-91","article-title":"PPAR\u03b1 downregulates airway inflammation induced by lipopolysaccharide in the mouse","volume":"6","author":"Delayre-Orthez","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejmech.2018.01.049_bib3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/j.1365-2222.2004.02082.x","article-title":"Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse","volume":"34","author":"Delayre-Orthez","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejmech.2018.01.049_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00063030-200317030-00005","article-title":"Role of novel biological therapies in psoriatic arthritis","volume":"17","author":"Braun","year":"2003","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejmech.2018.01.049_bib5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2165\/00003495-199957060-00014","article-title":"Etanercept","volume":"57","author":"Jarvis","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2018.01.049_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00063030-200115040-00005","article-title":"Tumour necrosis Factor-\u03b1 blockers in rheumatoid Arthritis","volume":"15","author":"Richard-Miceli","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejmech.2018.01.049_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2125.2001.00321.x","article-title":"Anti-TNF agents for rheumatoid arthritis, Br","volume":"51","author":"Seymour","year":"2001","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04146.x","article-title":"How tumour necrosis factor blockers interfere with tuberculosis immunity","volume":"161","author":"Harris","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0006-8993(01)02743-3","article-title":"Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy","volume":"913","author":"Sommer","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2018.01.049_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1529-8027.2001.01010.x","article-title":"Etanercept reduces hyperalgesia in experimental painful neuropathy","volume":"6","author":"Sommer","year":"2001","journal-title":"J.\u00a0Peripher. Nerv. Syst."},{"key":"10.1016\/j.ejmech.2018.01.049_bib11","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00586-011-1854-y","article-title":"Etanercept attenuates pain-related behavior following compression of the dorsal root ganglion in the rat","volume":"20","author":"Watanabe","year":"2011","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.ejmech.2018.01.049_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbd.2013.08.012","article-title":"Antidepressants suppress neuropathic pain by a peripheral \u03b22-adrenoceptor mediated anti-TNF\u03b1 mechanism","volume":"60","author":"Bohren","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2018.01.049_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","article-title":"The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines","volume":"229","author":"Austin","year":"2010","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/01.wnl.0000265062.92340.a5","article-title":"Differential expression of cytokines in painful and painless neuropathies","volume":"69","author":"Uceyler","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2018.01.049_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-7-27","article-title":"Tnf-alpha and neuropathic pain - a review","volume":"7","author":"Leung","year":"2010","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ejmech.2018.01.049_bib16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/WNL.56.10.1371","article-title":"TNF-alpha expression in painful and nonpainful neuropathies","volume":"56","author":"Empl","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2018.01.049_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00401-003-0689-y","article-title":"Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies","volume":"105","author":"Lindenlaub","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.spinee.2015.10.038","article-title":"Elevated levels of tumor necrosis factor-\u03b1 and TNFR1 in recurrent herniated lumbar discs correlate with chronicity of postoperative sciatic pain","volume":"16","author":"Andrade","year":"2016","journal-title":"Spine J."},{"key":"10.1016\/j.ejmech.2018.01.049_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2015.04.004","article-title":"Tumor necrosis factor-alpha is a potential diagnostic biomarker for chronic neuropathic pain after spinal cord injury","volume":"595","author":"Xu","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2018.01.049_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916633477","article-title":"The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system","volume":"12","author":"Kremer","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejmech.2018.01.049_bib21","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2174\/156802612801784443","article-title":"TNF \u03b1 signaling beholds thalidomide saga: a review of mechanistic role of TNF-\u03b1 signaling under thalidomide","volume":"12","author":"Majumder","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib22","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1097\/HJH.0000000000001086","article-title":"Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Brie","year":"2016","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ejmech.2018.01.049_bib23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.intimp.2005.12.007","article-title":"A\u00a0new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice","volume":"6","author":"Brustolim","year":"2006","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2018.01.049_bib24","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/bph.12131","article-title":"Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers: curcumin as TNF blocker","volume":"169","author":"Aggarwal","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib25","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1021\/jm00127a009","article-title":"Inhibition of cyclic adenosine-3\u2019,5\u2019-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogs","volume":"32","author":"Marivet","year":"1989","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib26","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/jm960827x","article-title":"9-benzyladenines:\u2009 potent and selective cAMP phosphodiesterase inhibitors","volume":"40","author":"Bourguignon","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0223-5234(02)01446-0","article-title":"Design, synthesis and structure\u2013activity relationships of a series of 9-substituted adenine derivatives as selective phosphodiesterase type-4 inhibitors","volume":"38","author":"Raboisson","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib28","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1016\/j.bmcl.2011.08.036","article-title":"New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam","volume":"21","author":"Bihel","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.049_bib29","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1021\/jm300514y","article-title":"Design, Synthesis, and Pharmacological Evaluation Of N-Acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors","volume":"55","author":"K\u00fcmmerle","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0960-894X(01)00701-6","article-title":"Selective urokinase-type plasminogen activator (uPA) inhibitors. part 1: 2-Pyridinylguanidines","volume":"12","author":"Barber","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.049_bib31","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1021\/jm9603936","article-title":"Structure\u2212activity relationships for the binding of arylpiperazines and arylbiguanides at 5-HT3 serotonin receptors","volume":"39","author":"Dukat","year":"1996","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib32","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.peptides.2005.07.024","article-title":"Structure\u2013activity relationships of neuropeptide FF and related peptidic and non-peptidic derivatives","volume":"27","author":"Vyas","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2018.01.049_bib33","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.bmc.2004.03.012","article-title":"Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists","volume":"12","author":"Aquino","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib34","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1124\/jpet.106.111559","article-title":"A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat","volume":"319","author":"Honore","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.01.049_bib35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/jm00028a009","article-title":"Synthesis and structure-activity studies of N,N\u2019-diarylguanidine derivatives. N-(1-naphthyl)-N\u2019-(3-ethylphenyl)-N\u2019-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist","volume":"37","author":"Reddy","year":"1994","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.neuropharm.2006.05.031","article-title":"Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A\/2C receptors","volume":"51","author":"Honda","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2018.01.049_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bmcl.2007.10.080","article-title":"Cyclic guanidines as dual 5-HT5A\/5-HT7 receptor ligands: structure\u2013activity relationship elucidation","volume":"18","author":"Peters","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.049_bib38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/jm501635e","article-title":"\u03b12-adrenoceptor antagonists: synthesis, pharmacological evaluation, and molecular modeling investigation of pyridinoguanidine, pyridino-2-aminoimidazoline and their derivatives","volume":"58","author":"Kelly","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib39","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1021\/jm800026x","article-title":"Guanidine and 2-aminoimidazoline aromatic derivatives as \u03b12-adrenoceptor antagonists. 2. exploring alkyl linkers for new antidepressants","volume":"51","author":"Rodriguez","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/jpet.109.164384","article-title":"Neuropeptide FF receptors have opposing modulatory effects on nociception","volume":"334","author":"Lameh","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.01.049_bib41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.peptides.2012.08.019","article-title":"Neuropeptide FF activates ERK and NF kappa B signal pathways in differentiated SH-SY5Y cells","volume":"38","author":"Sun","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2018.01.049_bib42","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.peptides.2010.12.001","article-title":"Neuropeptide FF receptor antagonist, RF9, attenuates the fever induced by central injection of LPS in mice","volume":"32","author":"Wang","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2018.01.049_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0091-3057(95)00085-B","article-title":"1,3-di-o-tolylguanidine (DTG) differentially affects acute and tonic formalin pain: antagonism by rimcazole","volume":"52","author":"Kest","year":"1995","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.ejmech.2018.01.049_bib44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2004.12.003","article-title":"Induction of plasminogen activator inhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury","volume":"132","author":"Yamanaka","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2018.01.049_bib45","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1002\/anie.200600493","article-title":"A\u00a0highly active catalyst for suzuki\u2013miyaura cross-coupling reactions of heteroaryl compounds","volume":"45","author":"Billingsley","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.01.049_bib46","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1002\/ejoc.201200918","article-title":"Room-Temperature suzuki\u2013miyaura coupling of heteroaryl chlorides and tosylates","volume":"2012","author":"Yang","year":"2012","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib47","doi-asserted-by":"crossref","first-page":"e4124","DOI":"10.1371\/journal.pone.0004124","article-title":"Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors","volume":"4","author":"Mairal","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.01.049_bib48","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/jm5017494","article-title":"Discovery of 1H-Pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase r-like endoplasmic reticulum Kinase (PERK)","volume":"58","author":"Smith","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib49","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.tetlet.2004.01.056","article-title":"A\u00a0facile reduction of 2-aminopyrimidines with triethylsilane and trifluoroacetic acid","volume":"45","author":"Baskaran","year":"2004","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.01.049_bib50","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1021\/jm800318d","article-title":"Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and stucture\u2212activity relationships","volume":"51","author":"Charifson","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib51","series-title":"Chemical Compounds","author":"Hendrickson","year":"2013"},{"key":"10.1016\/j.ejmech.2018.01.049_bib52","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1248\/cpb.28.1357","article-title":"Cyclic guanidines. IX. synthesis of 2-amino-3, 4-dihydroquinazolines as blood platelet aggregation inhibitors","volume":"28","author":"Ishikawa","year":"1980","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2018.01.049_bib53","series-title":"Mannoside Compounds and Methods of Use Thereof","author":"Janetka","year":"2012"},{"key":"10.1016\/j.ejmech.2018.01.049_bib54","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejpain.2007.10.002","article-title":"Sciatic nerve cuffing in mice: a model of sustained neuropathic pain","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejmech.2018.01.049_bib55","article-title":"The sciatic nerve cuffing model of neuropathic pain in mice","volume":"89","author":"Yalcin","year":"2014","journal-title":"J.\u00a0Vis. Exp. JoVE"},{"key":"10.1016\/j.ejmech.2018.01.049_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pain.2004.09.028","article-title":"What should we be measuring in behavioral studies of chronic pain in animals?","volume":"112","author":"Mogil","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2018.01.049_bib57","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ejpain.2008.01.010","article-title":"Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejmech.2018.01.049_bib58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2018.01.049_bib59","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib60","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.bmcl.2013.08.072","article-title":"2-Amino-6-chloro-3,4-dihydroquinazoline: a novel 5-HT3 receptor antagonist with antidepressant character","volume":"23","author":"Dukat","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.01.049_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2016.07.011","article-title":"Substituted conformationally restricted guanidine derivatives: probing the \u03b12-adrenoceptors\u2019 binding pocket","volume":"123","author":"McMullan","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib62","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1021\/jo200954c","article-title":"Pyridin-2-yl guanidine derivatives: conformational control induced by intramolecular hydrogen-bonding interactions","volume":"76","author":"Kelly","year":"2011","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib63","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1213\/ANE.0000000000000853","article-title":"The analgesic effect of rolipram, a phosphodiesterase 4 inhibitor, on chemotherapy-induced neuropathic pain in rats","volume":"121","author":"Kim","year":"2015","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejmech.2018.01.049_bib64","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neulet.2006.11.022","article-title":"Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain","volume":"412","author":"Liu","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2018.01.049_bib65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.01.013","article-title":"Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain","volume":"560","author":"Mika","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib66","first-page":"E589","article-title":"Pentoxifylline ameliorates mechanical hyperalgesia in a rat model of chemotherapy-induced neuropathic pain","volume":"19","author":"Kim","year":"2016","journal-title":"Pain Physician"},{"key":"10.1016\/j.ejmech.2018.01.049_bib67","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.intimp.2010.05.013","article-title":"The effects of 5HT3 receptor antagonist granisetron on inflammatory parameters and angiogenesis in the air-pouch model of inflammation","volume":"10","author":"Maleki-Dizaji","year":"2010","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2018.01.049_bib68","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1016\/j.bmc.2008.07.033","article-title":"Novel synthesis and pharmacological evaluation as \u03b12-adrenoceptor ligands of O-phenylisouronium salts","volume":"16","author":"Goonan","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.106.105890","article-title":"Painful purinergic receptors","volume":"324","author":"Donnelly-Roberts","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.01.049_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11302-008-9110-6","article-title":"Selective P2X7 receptor antagonists for chronic inflammation and pain","volume":"5","author":"Carroll","year":"2009","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2018.01.049_bib71","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1002\/chem.201301248","article-title":"Synthesis of C8 N9 annulated purines by iron-catalyzed C H amination","volume":"19","author":"Maes","year":"2013","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2018.01.049_bib72","doi-asserted-by":"crossref","first-page":"11171","DOI":"10.1021\/acs.jmedchem.6b01506","article-title":"Design and synthesis of a new series of 4-heteroarylamino-1\u2032-azaspiro[oxazole-5,3\u2032-bicyclo[2.2.2]octanes as \u03b17 nicotinic receptor agonists. 1. development of pharmacophore and early structure\u2013activity relationship","volume":"59","author":"Cook","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib73","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1016\/j.tet.2005.04.022","article-title":"Direct synthesis of new arylanthranilic acids via a Suzuki cross-coupling reaction from iodoisatins","volume":"61","author":"G\u00e9rard","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.01.049_bib74","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1039\/C4OB00798K","article-title":"CoPc-catalyzed selective radical arylation of anilines with arylhydrazines for synthesis of 2-aminobiaryls","volume":"12","author":"Jiang","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2018.01.049_bib75","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/adsc.201600390","article-title":"Enantioselective copper-catalyzed intramolecular N\u2212H bond insertion: synthesis of chiral 2-carboxytetrahydroquinolines","volume":"358","author":"Song","year":"2016","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2018.01.049_bib76","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jep.2015.03.015","article-title":"Antiplasmodial and anti-inflammatory effects of an antimalarial remedy from the Wayana amerindians, French Guiana: Takamalaim\u00eb (psidium acutangulum Mart. ex DC., Myrtaceae)","volume":"166","author":"Hou\u00ebl","year":"2015","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/9780470942390.mo110201","article-title":"Performing bronchoalveolar lavage in the mouse","volume":"2","author":"Daubeuf","year":"2012","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"10.1016\/j.ejmech.2018.01.049_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2011.12.041","article-title":"Tests and models of nociception and pain in rodents","volume":"211","author":"Barrot","year":"2012","journal-title":"Neuroscience"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341830062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T17:40:33Z","timestamp":1660412433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341830062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":78,"alternative-id":["S022352341830062X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.049","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylpyridine-2-ylguanidines and rigid mimetics as novel inhibitors of TNF\u03b1 overproduction: Beneficial action in models of neuropathic pain and of acute lung inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}